Industries — Dermatopathology & Skin Cancer Care
5 marketing mistakes dermatopathology & skin cancer care owners make
The five mistakes below cost skin cancer practice owners more money than any competitor does, and the first one is treating a measurement problem as a demand problem.
8 min read · Reviewed by both partners
None of these are exotic. They are the five that show up again and again when we read the numbers of a skin cancer practice that has been spending without moving.
They are listed in order of what they cost, not in order of how obvious they are. The expensive ones are rarely the obvious ones.
Skin cancer care markets to two audiences with opposite temperatures: a public that public-health agencies actively urge toward screening — skin cancer is the most commonly diagnosed cancer in the United States, per the CDC — and a professional audience of dermatologists and primary-care physicians whose referrals carry the surgical caseload.
Step by step
Buying attention before fixing the model
The instinct when growth stalls is more traffic. If the public who should be screened, and the dermatologists and physicians who refer the confirmed cases then added traffic amplifies a leak and the invoice arrives either way. Diagnose first; it is the cheapest step in the sequence.
Not knowing which source produced the revenue
Most skin cancer practice operators can state last quarter’s spend and not last quarter’s source mix. Without that, every budget decision after it is a guess wearing a decimal point.
Ignoring the vertical’s own rulebook
Patient-facing screening campaigns and referrer-facing clinical credibility are different machines, and a practice in this field usually needs both running at once. Generic playbooks discover this after the money is spent.
Underfunding the thing that already works
Almost every skin cancer practice has one channel quietly outperforming the rest — often screening-awareness content and campaigns timed to skin-check seasons. It is usually the one nobody has bothered to systematize, because it never asked for budget.
Killing programs at month four
Compounding channels look like failures right up until they do not. Programs get cancelled one quarter before payback more often than they get cancelled for being genuinely broken.
Common mistakes
Confusing activity with progress
A busy quarter of posting, posting, and posting produces a report full of numbers and a bank balance that has not moved. Ask what each activity was supposed to change.
Hiring for execution before strategy
A freelancer executing an undiagnosed plan produces well-made wrong work. For a skin cancer practice the sequencing matters more than the staffing.
Frequently Asked Questions
5 marketing mistakes dermatopathology & skin cancer care owners make?
None of these are exotic. They are the five that show up again and again when we read the numbers of a skin cancer practice that has been spending without moving.
What should a business owner do with this before booking an Assessment?
It sits under Dermatopathology & Skin Cancer Care in the Growth Scaling Method. The next step for an owner is the $1,500 Assessment, which reads your own numbers against everything described above.
What is the investment?
The one-time Foundation runs $4,500. Whether a monthly program follows, and at what level above the $5,000 floor, is a decision the Plan of Action makes with the numbers in hand.
Who works on the account?
The two founders, directly. David Mitroff, Ph.D., handles strategy; Steven Lockhart handles systems and measurement. Nothing is passed to a junior team.
References
- www.ama-assn.org — primary source
- medlineplus.gov — primary source
- www.uspto.gov — primary source
Find out which of these is costing you
Two hours and your real numbers name the constraint. The rest of the list stops mattering once you know.
Growth-Scaling is a marketing and business-scaling firm. It is not a licensed practitioner in any client vertical and does not provide medical, legal, financial, or contracting services; all industry content on this site is marketing and growth guidance for owners in those fields. Figures describing past engagements refer to specific businesses under specific conditions and are not a prediction of any future result. No outcome is promised.
Written by Steven Lockhart, reviewed by David Mitroff, Ph.D. Figures and regulatory details reflect the cited public sources; requirements vary by state and situation. Growth-Scaling is a marketing and business-scaling firm, not a licensed practitioner in any client vertical.